
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+8
At Kyowa Kirin International (KKI), commitment to life is at our core. We strive to answer the unmet medical needs of patients, their families, and the medical professionals who care for them. With more than 700 people focused on this purpose, we are a rapidly growing specialty biopharmaceutical company, engaged in the development and commercialisation of innovative medicines in the therapy areas of oncology, nephrology and central nervous system (CNS) across Europe and the Middle East. KKI, headquartered in Marlow, England, and Galashiels, Scotland, is owned by Kyowa Kirin Co., Ltd (KKC), of Japan. Founded in 1949, KKC has a...
Oncology,nephrology,central nervous system,biotechnology,antibodies,drug discovery,clinical development,rare disease,pharmaceuticals,specialty pharmaceuticals,biopharmaceuticals,neurology,and hematology / haematology
Kyowa kirin international plc operates in the Pharmaceutical manufacturing industry.
Kyowa kirin international plc's revenue is 11m - 100m
Kyowa kirin international plc has 501 - 1000 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.